Home - Products - Others - Other Targets - Calcitonin N-Terminal Flanking Peptide, human

Calcitonin N-Terminal Flanking Peptide, human

CAS No. 118277-01-3

Calcitonin N-Terminal Flanking Peptide, human( ——— )

Catalog No. M40945 CAS No. 118277-01-3

Calcitonin N-Terminal Flanking Peptide, human; N – Procalcitonin

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Calcitonin N-Terminal Flanking Peptide, human
  • Note
    Research use only, not for human use.
  • Brief Description
    Calcitonin N-Terminal Flanking Peptide, human; N – Procalcitonin
  • Description
    Calcitonin N-Terminal Flanking Peptide, human; N – Procalcitonin
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    118277-01-3
  • Formula Weight
    6220.84
  • Molecular Formula
    C264H426N74O97S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tyrphostin 8

    Tyrphostin 8(4-Hydroxybenzylidenemalononitrile) is a potent GTPase inhibitor that inhibits EGFR kinase with an IC50 of 560 μM.

  • Procodazole

    Procodazole is a non-specific active immunoprotective agent against viral and bacterial infections, used as a potentiator.

  • Fosravuconazole L-ly...

    FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.